Wearable Continuous Glucose Monitoring Devices Market is seeing fastest growth. Market size is set to reach US$32.48 billion by 2033 at a CAGR of 10.3% . North America leads the market with 45% market share | Major Players & Tech partnerships.

Wearable Continuous Glucose Monitoring Devices Market reached US$12.20 billion in 2024 and is expected to reach US$32.48 billion by 2033, growing at a CAGR of 10.3% during the forecast period 2025-2033, according to DataM intelligence research.

The Wearable Continuous Glucose Monitoring Devices market is growing due to rising diabetes prevalence, demand for real-time glucose tracking, technological advancements, and increasing awareness of personalized, non-invasive, and convenient diabetes management solutions.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/wearable-continuous-glucose-monitors-market?prtk

United States: Key Industry Developments

✅ January 2026: Senseonics announced Eversense 365 CGM, the world's longest‐lasting implantable continuous glucose monitoring system with a 12‐month sensor life, enhancing user comfort and reducing the need for frequent replacements.

✅ September 2025: Biolinq received FDA clearance for Biolinq Shine, a needle‐free wearable CGM patch providing real‐time glucose tracking with integrated activity and sleep metrics, targeting broader consumer adoption.

✅ September 2025: At EASD 2025, Dexcom spotlighted upcoming CGM feature enhancements, including advanced glucose biosensing capabilities designed to improve health outcomes and cost effectiveness across diabetes types.

Japan / Asia Pacific: Key Industry Developments

✅ January 2026: At CES 2026, Sensura showcased a non‐invasive CGM monitoring wearable prototype designed to track glucose trends without invasive sensors, signaling early‐stage technology that could shape APAC wearable adoption.

✅ October 2025: Dexcom's CGM data demonstrated real‐world benefits for type 2 diabetes care, highlighting market expansion potential in regions including Japan via increased clinical evidence supporting CGM cost‐effectiveness.

✅ May 2025: Biolinq's needle‐free biosensor patch launch technology reflects broader innovation influencing markets like Japan, where non‐invasive wearables could gain regulatory interest and eventual rollout.

Wearable Continuous Glucose Monitoring Devices Market Recent M&A activities:-

→ In October 2025, OSR Holdings, Inc. executed a definitive acquisition of Woori IO Co., Ltd., a South Korea-based pioneer in non‐invasive continuous glucose monitoring (CGM) technology. Under the share exchange deal, Woori IO shareholders received newly issued OSR Holdings Co., Ltd. shares worth approximately KRW 15 billion ( $10.5 million) positioning Woori IO as a wholly owned subsidiary focused on wearable, needle‐free glucose monitoring technologies.

→ In December 2025, shareholders of Woori IO formally approved a share exchange to integrate Woori IO into OSR Holdings Co., Ltd. as a wholly owned subsidiary, completing a key step toward global wearable CGM commercialization, including planned regulatory and clinical initiatives.

→ In January 2025, XR Immersive Technologies Inc. acquired the continuous glucose monitoring (CGM) technology developed by InsulinQ to expand its healthcare portfolio into wearable glucose monitoring solutions. The transaction was completed through the issuance of 4,000,000 common shares at a deemed price of $0.75 per share (total consideration $3 million), marking the company's strategic entry into CGM wearables.

Wearable Continuous Glucose Monitoring Devices Market key Players:-

Dexcom, Inc., Abbott., Medtronic, Senseonics, F. Hoffmann-La Roche Ltd, and Afon Technology., among others.

Top 5 Key Players Analysis:-

Abbott Laboratories - 39% market share and often ranked #1 globally for CGM sales.
Known for its FreeStyle Libre wearable CGM systems, Abbott leads with broad adoption due to affordability and strong global distribution.

Dexcom, Inc. - 32% market share; typically the second‐largest CGM provider.
Specializes in highly accurate real‐time CGM systems like the G7, with strong integration into digital health platforms and smartphone apps.

Medtronic plc - 14% market share, a major established diabetes tech player.
Offers CGM solutions often integrated with insulin pumps (e.g., Guardian systems), focusing on comprehensive diabetes management.

Senseonics Holdings, Inc. - 9% market share (smaller niche).
Known for its implantable CGM system (Eversense) that provides long‐term glucose monitoring with extended sensor life.

F. Hoffmann‐La Roche Ltd (Roche) -2.5% market share (smaller contributor).
Competes through the Accu‐Chek Insight CGM and leverages broad diagnostics and healthcare networks, especially in Europe.

Wearable Continuous Glucose Monitoring Devices Market Top Technological Partnerships (2026 & 2025):-

Dexcom + Oura Ring (Jan 2026): Integrated G7 CGM data into Oura's wellness platform for 2M users, combining sleep/glucose insights to optimize metabolic health with real-time alerts preventing 30% nocturnal hypoglycemia events.

Abbott + Medtronic (Sep 2025): Launched Instinct sensor built on FreeStyle Libre tech for MiniMed 780G pumps, enabling first cross-company automated insulin delivery across 1.5M Type 1 patients with 75% time-in-range improvement.

Sequel Med Tech + Senseonics (Apr 2025): Commercial agreement pairs twiist AID system with Eversense 365 implantable CGM, creating world's first one-year closed-loop solution compatible with 500K global insulin pump users.

Dario Health + Dexcom (Jun 2025): Embedded G7 CGM readings into Dario's AI metabolic app serving 1M chronic disease patients, delivering predictive alerts that cut A1c averages 1.2% through personalized nutrition coaching.

Glucotrack + Trinity Biotech (Jan 2025): Co-developed implantable CBGM eliminating wearables for 3-year continuous monitoring, targeting 50% of non-CGM diabetes patients with factory-calibrated sensors and smartphone connectivity.

📌 Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=wearable-continuous-glucose-monitors-market?prtk

Wearable Continuous Glucose Monitoring Devices Market Market Drivers :-

The growing incidence of diabetes worldwide continues to be the primary engine driving demand for wearable CGM devices. As more patients seek proactive glucose control, adoption of non‐stop monitoring solutions rises sharply.

Estimates suggest diabetes affects 8-10% of the global population, fuelling a projected 15-20% growth in CGM demand over coming years.

Continuous improvements in sensor accuracy, miniaturization, and comfort are transforming CGM wearables from niche clinical tools into user‐friendly everyday health tech.

Hybrid devices that integrate insulin delivery, Bluetooth connectivity, and real‐time smartphone analytics boost adoption and user engagement.

AI and IoT integration further enhances predictive insights, increasing appeal among both clinicians and health‐conscious consumers.

Wearables empower personalized glucose management outside clinical settings, supporting a shift to preventive health care rather than reactive treatment.

The market isn't just driven by diabetics health‐aware consumers now adopt CGM wearables to optimize diet, fitness, and metabolic health.

Users increasingly prefer real‐time glucose tracking with minimal invasiveness, reducing reliance on traditional fingerstick methods a key reason CGM wearable adoption continues to accelerate.

Wearable Continuous Glucose Monitoring Devices Market Regional Insights:-

North America
North America is the largest wearable CGM market, contributing around 45% of global market share due to high diabetes prevalence, advanced healthcare infrastructure, and favorable reimbursement policies.
The U.S. dominates this region, supported by strong adoption of FDA‐cleared wearable CGM devices and continuous innovation in diabetes management technologies.

Europe
Europe accounts for approximately 27% of the global wearable CGM market share, propelled by increasing diabetes awareness and structured reimbursement programs.
Germany, the UK, and France lead regional adoption, with growing integration of CGM into clinical care pathways.

Asia Pacific
Asia Pacific holds about 24% of the market share, with rapid growth driven by rising diabetes prevalence and expanding healthcare access in China, India, and Japan.
The region is also the fastest‐growing segment, supported by improving infrastructure and increasing consumer affordability of wearable CGM devices.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/wearable-continuous-glucose-monitors-market?prtk

Wearable Continuous Glucose Monitoring Devices Market Market Segmentation

By Component

• Sensors (60% share): Disposable 14-day Dexcom G7 sensors dominate with 95% market penetration, generating $3.2B annually across 5M Type 1 users requiring weekly replacements.
• Transmitters (20%): Reusable 90-day Abbott FreeStyle Libre transmitters sync data every 15 minutes, reducing costs 40% versus traditional fingerstick testing.
• Receiver/Display (15%): Smartphone integration replaces dedicated screens, serving 80% consumers through Apple Health/Google Fit ecosystems.
• Others (5%): Includes charging docks and calibration kits.

By Indication

• Type 1 Diabetes (70%): CGM essential for 1.5M U.S. patients on insulin pumps, achieving 75% time-in-range via closed-loop systems like Medtronic 780G.
• Type 2 Diabetes (30%): Late-stage insulin-dependent T2D patients adopt CGM, cutting A1c 1.2% through Dexcom Clarity retrospective analysis.

By Age Group

• Adults (55%): Working-age T1D patients drive 60% volume with seamless smartphone integration for continuous office monitoring.
• Children (25%): Pediatric endocrinologists mandate CGM for nocturnal hypoglycemia prevention, reducing ER visits 45% in 500K youth cases.
• Geriatrics (20%): Simplified Abbott LibreLinkUp app enables caregiver remote monitoring for 2M elderly patients with dexterity challenges.

This research report delivers actionable insights, data-driven analysis, and future-ready perspectives that enable informed decision-making, reduce market risks, and uncover growth opportunities across the industry

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.